Bilirubin and Biliverdin Treatment of Atherosclerotic Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bilirubin and Biliverdin Treatment of Atherosclerotic Diseases

Published:2007-01 Issue:1 Volume:6 Page:39-43
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Öllinger R.,Yamashita K.,Bilban Martin,Erat A.,Kogler P.,Thomas M.,Csizmadia E.,Usheva A.,Margreiter R.,Bach Fritz H.

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.6.1.3700

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bile pigments in emergency and critical care medicine;European Journal of Medical Research;2022-10-29

2. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity;Arthritis Research & Therapy;2021-06-08

3. Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets;Frontiers in Immunology;2021-03-12

4. INDUCTION OF CELL APOPTOSIS BY BILIVERDIN REDUCTASE INHIBITOR IN MCF-7 AND MDA-MB-468 BREAST CANCER CELL LINES: EXPERIMENTAL AND IN SILICO STUDIES;EXCLI J;2021

5. Nonlinear relationship between serum total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation;Journal of International Medical Research;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP